Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Dec 10;15(12):9104-34.
doi: 10.3390/molecules15129104.

Experimental models for assaying microvascular endothelial cell pathophysiology in stroke

Affiliations
Review

Experimental models for assaying microvascular endothelial cell pathophysiology in stroke

Susanna Camós et al. Molecules. .

Abstract

It is important to understand the molecular mechanisms underlying neuron death following stroke in order to develop effective neuroprotective strategies. Since studies on human stroke are extremely limited due to the difficulty in collecting post-mortem tissue at different time points after the onset of stroke, brain ischaemia research focuses on information derived from in-vitro models of neuronal death through ischaemic injury [1]. This review aims to provide an update on the different in-vitro stroke models with brain microvascular endothelial cells that are currently being used. These models provide a physiologically relevant tool to screen potential neuroprotective drugs in stroke and to study the molecular mechanisms involved in brain ischaemia.

PubMed Disclaimer

References

    1. Taoufik E., Probert L. Ischemic neuronal damage. Curr. Pharm. Des. 2008;14:3565–3573. doi: 10.2174/138161208786848748. - DOI - PubMed
    1. Ginsberg M.D. Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology. 2008;55:363–389. doi: 10.1016/j.neuropharm.2007.12.007. - DOI - PMC - PubMed
    1. Tabakman R., Jiang H., Shahar I., Arien-Zakay H., Levine R.A., Lazarovici P. Neuroprotection by NGF in the PC12 in vitro OGD model: involvement of mitogen-activated protein kinases and gene expression. Ann. NY Acad. Sci. 2005;1053:84–96. doi: 10.1196/annals.1344.008. - DOI - PubMed
    1. Liebeskind D.S. Neuroprotection from the collateral perspective. IDrugs. 2005;8:222–228. - PubMed
    1. Staton C.A., Stribbling S.M., Tazzyman S., Hughes R., Brown N.J., Lewis C.E. Current methods for assaying angiogenesis in vitro and in vivo. Int. J. Exp. Pathol. 2004;85:233–248. doi: 10.1111/j.0959-9673.2004.00396.x. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances